YIH
MDGL icon

Y-Intercept (HK)’s Madrigal Pharmaceuticals MDGL Stock Holding History

Y-Intercept (HK)’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
+5,560
New +$2.85M 0.06% 477
2025
Q3 		– Sell
-1,415
Closed -$428K – 1846
2025
Q2 		$428K Buy
+1,415
New +$422K 0.01% 1253
2024
Q4 		– Sell
-1,736
Closed -$368K – 1468
2024
Q3 		$368K Buy
+1,736
New +$444K 0.02% 922
2024
Q1 		– Sell
-1,551
Closed -$359K – 1607
2023
Q4 		$359K Buy
+1,551
New +$271K 0.03% 755
2023
Q1 		– Sell
-871
Closed -$253K – 1393
2022
Q4 		$253K Buy
+871
New +$85.2K 0.04% 732

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s MDGL Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2026: 5,560 shares worth $2.99M. The stake represents 0.06% of the portfolio and ranks #477 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in MDGL as recently as Q2 2025.

Y-Intercept (HK) first reported a position in MDGL in Q4 2022 and has held it in 5 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Y-Intercept (HK) held 5,560 shares of Madrigal Pharmaceuticals worth $2.99M as of Q2 2026.
  • Madrigal Pharmaceuticals was a new Y-Intercept (HK) position in Q2 2026.
  • Madrigal Pharmaceuticals made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #477 holding.
  • Y-Intercept (HK) first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.